Go Pro

Halliburton (HAL) Financials

Halliburton logo
$36.86 -0.21 (-0.58%)
Closing price 09/8/2026 03:59 PM Eastern
Extended Trading
$36.92 +0.07 (+0.18%)
As of 04:00 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.
Annual Income Statements for Halliburton

Annual Income Statements for Halliburton

This table shows Halliburton's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Net Income / (Loss) Attributable to Common Shareholders
-671 -5,763 -463 1,656 -1,131 -2,945 1,457 1,572 2,638 2,501 1,283
Consolidated Net Income / (Loss)
-667 -5,769 -468 1,657 -1,129 -2,942 1,468 1,595 2,662 2,516 1,292
Net Income / (Loss) Continuing Operations
-662 -5,767 -449 1,657 -1,129 -2,942 1,468 1,595 2,772 2,516 1,292
Total Pre-Tax Income
-936 -7,625 682 1,814 -1,122 -3,220 1,252 2,110 3,363 3,234 1,771
Total Operating Income
-165 -6,770 1,374 2,467 -448 -2,436 1,800 2,707 4,083 3,822 2,260
Total Gross Profit
2,520 870 2,277 2,986 2,285 1,545 2,016 3,313 4,360 4,301 3,484
Total Revenue
23,633 15,887 20,620 23,995 22,408 14,445 15,295 20,297 23,018 22,944 22,184
Operating Revenue
23,633 15,887 20,620 23,995 22,408 14,445 15,295 20,297 23,018 22,944 22,184
Total Cost of Revenue
21,113 15,017 18,343 21,009 20,123 12,900 13,279 16,984 18,658 18,643 18,700
Operating Cost of Revenue
21,113 15,017 18,343 21,009 20,123 12,900 13,279 16,984 18,658 18,643 18,700
Total Operating Expenses
2,685 7,640 903 519 2,733 3,981 216 606 277 479 1,224
Selling, General & Admin Expense
200 226 256 254 227 182 204 240 226 239 239
Other Operating Expenses / (Income)
- - - - - - 0.00 0.00 51 124 154
Restructuring Charge
2,485 7,414 647 265 2,506 3,799 12 366 0.00 116 831
Total Other Income / (Expense), net
-771 -855 -692 -653 -674 -784 -554 -597 -610 -580 -480
Interest & Investment Income
-447 -639 -593 -554 -569 -505 -520 -463 -395 -353 -352
Other Income / (Expense), net
-324 -216 -99 -99 -105 -111 -34 -92 -215 -227 -128
Income Tax Expense
-274 -1,858 1,131 157 7.00 -278 -216 515 701 718 479
Net Income / (Loss) Attributable to Noncontrolling Interest
4.00 -6.00 -5.00 1.00 2.00 3.00 11 23 24 15 9.00
Basic Earnings per Share
- - - $1.89 ($1.29) - - - $0.00 $0.00 $0.00
Weighted Average Basic Shares Outstanding
853M 861M 870M 875M 875M 881M 892M 904M 899M 882M 853M
Diluted Earnings per Share
($0.79) ($6.69) ($0.53) $1.89 ($1.29) - - - $0.00 $0.00 $0.00
Weighted Average Diluted Shares Outstanding
853M 861M 870M 877M 875M 881M 892M 908M 902M 883M 853M
Weighted Average Basic & Diluted Shares Outstanding
853M 861M 870M 872.54M 875M 881M 892M 1.81B 1.78B 868.09M 837.55M

Quarterly Income Statements for Halliburton

This table shows Halliburton's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026 Q2 2026
Period end date 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026 6/30/2026
Net Income / (Loss) Attributable to Common Shareholders
661 606 709 571 615 204 472 18 589 461 534
Consolidated Net Income / (Loss)
661 609 713 580 614 203 480 20 589 464 538
Net Income / (Loss) Continuing Operations
563 609 713 580 614 203 480 20 589 464 538
Total Pre-Tax Income
835 787 920 734 793 306 611 219 635 569 664
Total Operating Income
1,058 987 1,032 871 932 431 727 356 746 679 778
Total Gross Profit
1,133 1,082 1,123 1,070 1,026 879 819 856 930 783 804
Total Revenue
5,739 5,804 5,833 5,697 5,610 5,417 5,510 5,600 5,657 5,402 5,714
Operating Revenue
5,739 5,804 5,833 5,697 5,610 5,417 5,510 5,600 5,657 5,402 5,714
Total Cost of Revenue
4,606 4,722 4,710 4,627 4,584 4,538 4,691 4,744 4,727 4,619 4,910
Operating Cost of Revenue
4,606 4,722 4,710 4,627 4,584 4,538 4,691 4,744 4,727 4,619 4,910
Total Operating Expenses
75 95 91 199 94 448 92 500 184 104 26
Selling, General & Admin Expense
60 61 62 55 61 62 60 58 59 62 75
Other Operating Expenses / (Income)
15 34 29 28 33 30 32 50 42 42 46
Restructuring Charge
- 0.00 0.00 116 - 356 0.00 392 83 0.00 -95
Total Other Income / (Expense), net
-327 -200 -112 -137 -139 -125 -116 -137 -102 -110 -114
Interest & Investment Income
-98 -92 -92 -85 -84 -86 -92 -88 -86 -82 -83
Other Income / (Expense), net
-229 -108 -20 -52 -55 -39 -24 -49 -16 -28 -31
Income Tax Expense
168 178 207 154 179 103 131 199 46 105 126
Net Income / (Loss) Attributable to Noncontrolling Interest
6.00 3.00 4.00 9.00 -1.00 -1.00 8.00 2.00 - 3.00 4.00
Basic Earnings per Share
- $0.68 $0.80 $0.65 - $0.24 $0.55 $0.02 ($0.81) $0.55 $0.64
Weighted Average Basic Shares Outstanding
899M 889M 884M 881M 882M 866M 857M 849M 853M 837M 836M
Diluted Earnings per Share
- $0.68 $0.80 $0.65 - $0.24 $0.55 $0.02 ($0.81) $0.55 $0.64
Weighted Average Diluted Shares Outstanding
902M 891M 886M 881M 883M 866M 857M 850M 853M 839M 838M
Weighted Average Basic & Diluted Shares Outstanding
1.78B 1.77B 1.77B 878.50M 868.09M 859.72M 852.60M 841.63M 837.55M 835.40M 833.13M

Annual Cash Flow Statements for Halliburton

This table details how cash moves in and out of Halliburton's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Net Change in Cash & Equivalents
7,786 -6,068 -1,672 -329 260 295 481 -698 -82 354 -412
Net Cash From Operating Activities
2,906 -1,703 2,468 3,157 2,445 1,881 1,911 2,242 3,458 3,865 2,926
Net Cash From Continuing Operating Activities
2,906 -1,703 2,468 3,157 2,445 1,881 1,911 2,242 3,458 3,865 2,926
Net Income / (Loss) Continuing Operations
-667 -5,769 -468 1,657 -1,129 -2,942 1,468 1,595 2,662 2,516 1,292
Consolidated Net Income / (Loss)
-667 -5,769 -468 1,657 -1,129 -2,942 1,468 1,595 2,662 2,516 1,292
Depreciation Expense
1,835 1,503 1,556 1,606 1,625 1,058 904 940 998 1,079 1,136
Non-Cash Adjustments To Reconcile Net Income
944 2,832 1,272 614 2,650 3,759 -260 578 113 225 279
Changes in Operating Assets and Liabilities, net
794 -269 108 -720 -701 6.00 -201 -871 -315 45 219
Net Cash From Investing Activities
-2,192 -710 -1,927 -1,993 -1,445 -486 -534 -967 -1,659 -1,654 -1,325
Net Cash From Continuing Investing Activities
-2,192 -710 -1,927 -1,993 -1,445 -486 -534 -967 -1,659 -1,654 -1,325
Purchase of Property, Plant & Equipment
-2,184 -798 -1,373 -2,026 -1,530 -728 -799 -1,011 -1,379 -1,442 -1,254
Acquisitions
-39 -31 -628 -187 - - - - -13 -166 -548
Purchase of Investments
- -92 - - - - -5.00 -75 -492 -438 -202
Sale of Property, Plant & Equipment
168 222 158 218 190 286 257 200 195 223 185
Divestitures
- - - - - - - - 0.00 0.00 120
Sale and/or Maturity of Investments
- 96 - - - 0.00 87 0.00 131 214 444
Other Investing Activities, net
-137 -107 -84 2.00 -105 -44 -74 -81 -101 -45 -70
Net Cash From Financing Activities
7,081 -3,540 -2,161 -1,419 -695 -1,007 -838 -1,798 -1,671 -1,730 -1,987
Net Cash From Continuing Financing Activities
7,081 -3,540 -2,161 -1,419 -695 -1,007 -838 -1,798 -1,671 -1,730 -1,987
Repayment of Debt
88 -3,171 -1,693 -584 -13 -1,654 -700 -1,242 -305 -100 -389
Repurchase of Common Equity
- 0.00 0.00 -400 -100 -100 0.00 -250 -800 -1,005 -1,007
Payment of Dividends
-614 -620 -626 -630 -630 -278 -161 -435 -576 -600 -579
Issuance of Debt
7,440 65 - 0.00 -70 938 -56 -100 -126 -130 -110
Other Financing Activities, net
167 186 158 195 118 87 79 229 136 105 98
Effect of Exchange Rate Changes
-9.00 -115 -52 -74 -45 -93 -58 -175 -210 -127 -26
Cash Interest Paid
380 659 594 556 534 509 517 487 460 441 432
Cash Income Taxes Paid
370 -20 -178 178 363 300 214 354 616 538 639

Quarterly Cash Flow Statements for Halliburton

This table details how cash moves in and out of Halliburton's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026 Q2 2026
Period end date 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026 6/30/2026
Net Change in Cash & Equivalents
228 -373 247 40 440 -814 234 -12 180 -203 45
Net Cash From Operating Activities
1,410 487 1,081 841 1,456 377 896 488 1,165 273 824
Net Cash From Continuing Operating Activities
1,410 487 1,081 841 1,456 377 896 488 1,165 273 824
Net Income / (Loss) Continuing Operations
667 609 713 580 614 203 480 20 589 464 538
Consolidated Net Income / (Loss)
667 609 713 580 614 203 480 20 589 464 538
Depreciation Expense
256 263 271 270 275 277 284 285 290 295 296
Non-Cash Adjustments To Reconcile Net Income
4.00 -44 121 271 -123 51 -122 394 -44 -234 -75
Changes in Operating Assets and Liabilities, net
483 -341 -24 -280 690 -154 254 -211 330 -252 65
Net Cash From Investing Activities
-535 -381 -393 -436 -444 -784 -256 -86 -199 -243 -383
Net Cash From Continuing Investing Activities
-535 -381 -393 -436 -444 -784 -256 -86 -199 -243 -383
Purchase of Property, Plant & Equipment
-399 -330 -347 -339 -426 -302 -354 -261 -337 -192 -235
Acquisitions
- 0.00 - - - -461 -46 -11 -30 -97 -111
Purchase of Investments
-191 -88 - -38 -118 -96 -19 -13 -74 -2.00 -91
Sale of Property, Plant & Equipment
59 49 59 41 74 49 40 49 47 42 79
Sale and/or Maturity of Investments
19 0.00 - 14 77 41 24 163 216 27 22
Other Investing Activities, net
-23 -12 76 -136 -51 -15 -21 -13 -21 -21 -47
Net Cash From Financing Activities
-544 -422 -416 -347 -545 -406 -405 -405 -771 -237 -382
Net Cash From Continuing Financing Activities
-544 -422 -416 -347 -545 -406 -405 -405 -771 -237 -382
Repurchase of Common Equity
-254 -250 -250 -196 -309 -250 -257 -250 -250 -100 -208
Payment of Dividends
-143 -151 -151 -150 -148 -147 -145 -144 -143 -142 -143
Issuance of Debt
-128 -21 -15 -1.00 -93 -9.00 -3.00 -11 -87 5.00 -31
Effect of Exchange Rate Changes
-103 -57 -25 -18 -27 -1.00 -1.00 -9.00 -15 4.00 -14
Cash Interest Paid
105 118 100 118 105 116 98 116 102 114 88
Cash Income Taxes Paid
88 95 188 86 169 165 217 136 121 102 138

Annual Balance Sheets for Halliburton

This table presents Halliburton's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Total Assets
36,942 27,000 25,085 25,982 25,377 20,680 22,321 23,255 24,683 25,587 25,010
Total Current Assets
20,070 11,677 10,777 11,151 11,212 9,475 9,943 10,952 11,543 12,382 11,398
Cash & Equivalents
10,077 4,009 2,337 2,008 2,268 2,563 3,044 2,346 2,264 2,618 2,206
Accounts Receivable
5,317 3,922 5,036 5,234 4,577 3,071 3,666 4,627 4,860 5,117 4,942
Inventories, net
2,993 2,275 2,396 3,028 3,139 2,349 2,361 2,923 3,226 3,040 2,976
Other Current Assets
1,156 886 1,008 881 1,228 1,492 872 1,056 1,193 1,607 1,274
Plant, Property, & Equipment, net
12,117 8,532 8,521 8,873 7,310 4,325 4,326 4,348 4,900 5,113 5,261
Total Noncurrent Assets
4,755 6,791 5,787 5,958 6,855 3,890 8,052 7,955 8,240 8,092 8,351
Goodwill
2,385 2,414 2,693 2,825 2,812 2,804 2,843 2,829 2,850 2,838 2,938
Noncurrent Deferred & Refundable Income Taxes
552 1,960 1,230 1,384 1,683 - 2,695 2,636 2,505 2,339 2,298
Other Noncurrent Operating Assets
1,818 2,417 1,864 1,749 2,360 1,910 2,514 2,490 2,885 2,915 3,115
Total Liabilities & Shareholders' Equity
36,942 27,000 25,085 25,982 25,377 20,680 22,321 23,255 24,683 25,587 25,010
Total Liabilities
21,447 17,552 16,736 16,438 17,352 15,697 15,593 15,278 15,250 15,039 14,505
Total Current Liabilities
5,337 4,023 4,862 4,802 4,878 4,421 4,306 5,345 5,608 6,050 5,588
Short-Term Debt
659 170 512 - 11 - - 224 0.00 381 0.00
Accounts Payable
2,019 1,764 2,554 3,018 2,432 1,573 2,353 3,121 3,147 3,189 3,133
Current Deferred & Payable Income Tax Liabilities
293 218 231 248 310 508 553 294 390 449 375
Current Employee Benefit Liabilities
862 544 746 714 604 517 493 634 689 711 767
Other Taxes Payable
- - - - - - - 349 370 328 291
Other Current Liabilities
806 697 819 822 1,521 1,128 907 723 1,012 992 1,022
Total Noncurrent Liabilities
16,110 13,529 11,874 11,636 12,474 11,276 11,287 9,933 9,642 8,989 8,917
Long-Term Debt
14,687 12,214 10,430 10,312 10,316 9,132 9,127 7,928 7,636 7,160 7,158
Noncurrent Employee Benefit Liabilities
479 574 609 483 525 562 492 408 408 414 428
Other Noncurrent Operating Liabilities
944 741 835 841 1,633 1,582 1,668 1,597 1,598 1,415 1,331
Total Equity & Noncontrolling Interests
15,495 9,448 8,349 9,544 8,025 4,983 6,728 7,977 9,433 10,548 10,505
Total Preferred & Common Equity
15,462 9,409 8,322 9,522 8,012 4,974 6,713 7,948 9,391 10,506 10,461
Total Common Equity
15,462 9,409 8,322 9,522 8,012 4,974 6,713 7,948 9,391 10,506 10,461
Common Stock
2,951 2,875 2,880 2,882 2,812 2,666 2,697 2,714 2,726 2,741 2,771
Retained Earnings
20,524 14,141 12,668 13,739 11,989 8,691 9,710 10,572 12,536 14,332 15,036
Treasury Stock
-7,650 -7,153 -6,757 -6,744 -6,427 -6,021 -5,511 -5,108 -5,540 -6,214 -6,983
Accumulated Other Comprehensive Income / (Loss)
-363 -454 -469 -355 -362 -362 -183 -230 -331 -353 -363
Noncontrolling Interest
33 39 27 22 13 9.00 15 29 42 42 44

Quarterly Balance Sheets for Halliburton

This table presents Halliburton's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q1 2026 Q2 2026
Period end date 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 3/31/2026 6/30/2026
Total Assets
24,442 24,683 24,654 25,152 25,331 25,587 25,179 25,377 25,164 25,142 25,828
Total Current Assets
11,600 11,543 11,423 11,878 12,043 12,382 11,529 11,671 11,638 11,535 11,882
Cash & Equivalents
2,036 2,264 1,891 2,138 2,178 2,618 1,804 2,038 2,026 2,003 2,048
Accounts Receivable
5,124 4,860 5,103 5,327 5,339 5,117 5,204 4,970 5,161 5,197 5,325
Inventories, net
3,336 3,226 3,258 3,282 3,194 3,040 3,044 3,071 3,095 3,019 3,056
Other Current Assets
1,104 1,193 1,171 1,131 1,332 1,607 1,477 1,592 1,356 1,316 1,453
Plant, Property, & Equipment, net
4,733 4,900 4,973 5,073 4,945 5,113 5,149 5,246 5,174 5,182 5,173
Total Noncurrent Assets
8,109 8,240 8,258 8,201 8,343 8,092 8,501 8,460 8,352 8,425 8,773
Goodwill
2,850 2,850 2,850 2,858 2,838 2,838 2,891 2,964 2,938 2,992 3,020
Noncurrent Deferred & Refundable Income Taxes
2,517 2,505 2,472 2,420 2,446 2,339 2,345 2,327 2,260 2,339 2,331
Other Noncurrent Operating Assets
2,742 2,885 2,936 2,923 3,059 2,915 3,265 3,169 3,154 3,094 3,422
Total Liabilities & Shareholders' Equity
24,442 24,683 24,654 25,152 25,331 25,587 25,179 25,377 25,164 25,142 25,828
Total Liabilities
15,253 15,250 14,972 15,106 14,979 15,039 14,770 14,830 14,918 14,317 14,776
Total Current Liabilities
5,419 5,608 5,379 5,576 5,460 6,050 5,823 5,844 5,954 5,537 5,887
Short-Term Debt
- 0.00 - - - 644 381 381 382 90 90
Accounts Payable
3,238 3,147 3,092 3,295 3,009 3,189 3,168 3,231 3,182 3,211 3,456
Current Deferred & Payable Income Tax Liabilities
266 390 428 402 482 449 362 341 354 384 359
Current Employee Benefit Liabilities
643 689 542 619 690 711 632 616 745 622 681
Other Taxes Payable
332 370 311 294 281 328 237 250 273 250 262
Other Current Liabilities
940 1,012 1,006 966 998 729 1,043 1,025 1,018 980 1,039
Total Noncurrent Liabilities
9,834 9,642 9,593 9,530 9,519 8,989 8,947 8,986 8,964 8,780 8,889
Long-Term Debt
7,783 7,636 7,637 7,638 7,639 7,160 7,160 7,163 7,157 7,070 7,071
Noncurrent Employee Benefit Liabilities
392 408 381 375 392 414 389 406 421 395 413
Other Noncurrent Operating Liabilities
1,659 1,598 1,575 1,517 1,488 1,415 1,398 1,417 1,386 1,315 1,405
Total Equity & Noncontrolling Interests
9,189 9,433 9,682 10,046 10,352 10,548 10,409 10,547 10,246 10,825 11,052
Total Preferred & Common Equity
9,150 9,391 9,636 10,000 10,296 10,506 10,367 10,505 10,203 10,780 11,010
Total Common Equity
9,150 9,391 9,636 10,000 10,296 10,506 10,367 10,505 10,203 10,780 11,010
Common Stock
2,689 2,726 2,662 2,663 2,700 2,741 2,720 2,692 2,733 2,752 2,662
Retained Earnings
12,018 12,536 12,988 13,450 13,865 14,332 14,389 14,716 14,590 15,355 15,722
Treasury Stock
-5,330 -5,540 -5,682 -5,781 -5,940 -6,214 -6,383 -6,547 -6,766 -6,984 -7,031
Accumulated Other Comprehensive Income / (Loss)
-227 -331 -332 -332 -329 -353 -359 -356 -354 -343 -343
Noncontrolling Interest
39 42 46 46 56 42 42 42 43 45 42

Annual Metrics And Ratios for Halliburton

This table displays calculated financial ratios and metrics derived from Halliburton's official financial filings.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Growth Metrics
- - - - - - - - - - -
Revenue Growth
-28.10% -32.78% 29.79% 16.37% -6.61% -35.54% 5.88% 32.70% 13.41% -0.32% -3.31%
EBITDA Growth
-81.36% -507.36% 151.63% 40.37% -73.02% -238.90% 279.32% 33.15% 33.78% -1.89% -30.08%
EBIT Growth
-109.60% -1,328.63% 118.25% 85.73% -123.35% -360.58% 169.34% 48.07% 43.71% -4.55% -40.70%
NOPAT Growth
-103.11% -4,003.03% 80.91% 349.12% -113.92% -443.75% 223.77% -3.04% 57.94% -8.00% -44.55%
Net Income Growth
-119.05% -764.92% 91.89% 454.06% -168.14% -160.58% 149.90% 8.65% 66.90% -5.48% -48.65%
EPS Growth
-119.22% -746.84% 92.08% 456.60% -168.25% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Cash Flow Growth
-28.46% -158.60% 244.92% 27.92% -22.55% -23.07% 1.59% 17.32% 54.24% 11.77% -24.30%
Free Cash Flow Firm Growth
-9.96% -298.35% 98.02% 3,920.54% 6.69% 253.13% -128.18% 174.42% 105.71% -7.49% -27.94%
Invested Capital Growth
-4.69% -14.16% -4.88% 5.27% -9.88% -42.45% 38.39% 7.59% 7.41% 6.27% -0.09%
Revenue Q/Q Growth
-13.50% -6.26% 10.26% -0.02% -3.22% -11.92% 7.30% 6.87% 0.69% -0.56% 0.21%
EBITDA Q/Q Growth
-51.89% -1.80% 16.65% 7.14% -68.59% 49.13% 34.71% 14.05% -3.16% 1.46% -3.88%
EBIT Q/Q Growth
-160.52% -1.17% 45.22% 11.07% -131.82% 38.30% 63.52% 19.84% -4.45% 1.36% -6.45%
NOPAT Q/Q Growth
-116.33% -0.37% -210.86% 778.80% -117.02% 38.98% 162.41% -13.92% 2.34% -3.96% -1.27%
Net Income Q/Q Growth
-352.65% -2.25% -329.41% 910.37% -194.64% 32.66% 254.59% -9.22% -0.15% -1.83% -1.90%
EPS Q/Q Growth
-363.33% 0.00% 0.00% 894.74% -194.85% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Cash Flow Q/Q Growth
-8.33% 9.27% -1.91% -4.79% 14.79% -21.95% 2.36% 27.31% 7.69% 1.20% -9.05%
Free Cash Flow Firm Q/Q Growth
-69.50% 59.45% -102.78% 21.01% 91.37% 83.27% -163.11% 401.87% 21.62% -7.86% -3.55%
Invested Capital Q/Q Growth
9.05% -4.95% -7.28% 2.46% -13.08% -28.32% 12.06% 1.38% -0.88% -0.50% -1.92%
Profitability Metrics
- - - - - - - - - - -
Gross Margin
10.66% 5.48% 11.04% 12.44% 10.20% 10.70% 13.18% 16.32% 18.94% 18.75% 15.71%
EBITDA Margin
5.70% -34.51% 13.73% 16.56% 4.78% -10.31% 17.46% 17.51% 20.66% 20.34% 14.73%
Operating Margin
-0.70% -42.61% 6.66% 10.28% -2.00% -16.86% 11.77% 13.34% 17.74% 16.66% 10.19%
EBIT Margin
-2.07% -43.97% 6.18% 9.87% -2.47% -17.63% 11.55% 12.88% 16.33% 15.63% 9.61%
Profit (Net Income) Margin
-2.82% -36.31% -2.27% 6.91% -5.04% -20.37% 9.60% 7.86% 11.56% 10.97% 5.82%
Tax Burden Percent
71.26% 75.66% -68.62% 91.35% 100.62% 91.37% 117.25% 75.59% 79.16% 77.80% 72.95%
Interest Burden Percent
191.41% 109.15% 53.49% 76.60% 202.89% 126.42% 70.89% 80.69% 89.49% 90.16% 83.07%
Effective Tax Rate
0.00% 0.00% 165.84% 8.65% 0.00% 0.00% -17.25% 24.41% 20.84% 22.20% 27.05%
Return on Invested Capital (ROIC)
-0.54% -24.56% -5.20% 12.95% -1.85% -13.46% 19.13% 15.39% 22.61% 19.47% 10.66%
ROIC Less NNEP Spread (ROIC-NNEP)
-10.80% -39.66% -0.06% 5.90% -11.81% -33.51% 6.72% 7.80% 12.41% 10.81% 3.44%
Return on Net Nonoperating Assets (RNNOA)
-3.65% -21.69% -0.06% 5.57% -11.00% -31.78% 5.94% 6.30% 7.97% 5.71% 1.61%
Return on Equity (ROE)
-4.20% -46.26% -5.26% 18.52% -12.85% -45.23% 25.07% 21.69% 30.58% 25.18% 12.27%
Cash Return on Invested Capital (CROIC)
4.26% -9.32% -0.20% 7.81% 8.55% 40.42% -13.08% 8.08% 15.46% 13.39% 10.75%
Operating Return on Assets (OROA)
-1.42% -21.85% 4.90% 9.27% -2.15% -11.06% 8.21% 11.48% 15.68% 14.27% 8.43%
Return on Assets (ROA)
-1.93% -18.04% -1.80% 6.49% -4.40% -12.78% 6.83% 7.00% 11.11% 10.01% 5.11%
Return on Common Equity (ROCE)
-4.19% -46.12% -5.24% 18.47% -12.83% -45.16% 25.02% 21.63% 30.46% 25.08% 12.22%
Return on Equity Simple (ROE_SIMPLE)
-4.31% -61.31% -5.62% 17.40% -14.09% -59.15% 21.87% 20.07% 28.35% 23.95% 0.00%
Net Operating Profit after Tax (NOPAT)
-116 -4,739 -905 2,253 -314 -1,705 2,111 2,046 3,232 2,973 1,649
NOPAT Margin
-0.49% -29.83% -4.39% 9.39% -1.40% -11.80% 13.80% 10.08% 14.04% 12.96% 7.43%
Net Nonoperating Expense Percent (NNEP)
10.25% 15.10% -5.14% 7.06% 9.97% 20.06% 12.41% 7.59% 10.20% 8.67% 7.23%
Return On Investment Capital (ROIC_SIMPLE)
- - - - - - - 12.69% 18.93% 16.20% 9.33%
Cost of Revenue to Revenue
89.34% 94.52% 88.96% 87.56% 89.80% 89.30% 86.82% 83.68% 81.06% 81.25% 84.30%
SG&A Expenses to Revenue
0.85% 1.42% 1.24% 1.06% 1.01% 1.26% 1.33% 1.18% 0.98% 1.04% 1.08%
R&D to Revenue
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Expenses to Revenue
11.36% 48.09% 4.38% 2.16% 12.20% 27.56% 1.41% 2.99% 1.20% 2.09% 5.52%
Earnings before Interest and Taxes (EBIT)
-489 -6,986 1,275 2,368 -553 -2,547 1,766 2,615 3,758 3,587 2,132
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
1,346 -5,483 2,831 3,974 1,072 -1,489 2,670 3,555 4,756 4,666 3,268
Valuation Ratios
- - - - - - - - - - -
Price to Book Value (P/BV)
1.62 4.36 4.57 2.22 2.51 3.21 2.94 4.32 3.37 2.27 2.27
Price to Tangible Book Value (P/TBV)
1.92 5.86 6.75 3.16 3.87 7.36 5.10 6.71 4.84 3.12 3.16
Price to Revenue (P/Rev)
1.06 2.58 1.84 0.88 0.90 1.11 1.29 1.69 1.38 1.04 1.07
Price to Earnings (P/E)
0.00 0.00 0.00 12.76 0.00 0.00 13.55 21.86 12.01 9.55 18.54
Dividend Yield
2.45% 1.52% 1.65% 2.98% 3.14% 1.74% 0.82% 1.27% 1.81% 2.50% 2.41%
Earnings Yield
0.00% 0.00% 0.00% 7.84% 0.00% 0.00% 7.38% 4.57% 8.33% 10.47% 5.39%
Enterprise Value to Invested Capital (EV/IC)
1.47 2.77 2.75 1.65 1.75 2.44 2.02 2.92 2.51 1.85 1.86
Enterprise Value to Revenue (EV/Rev)
1.29 3.11 2.26 1.23 1.26 1.56 1.69 1.98 1.61 1.27 1.30
Enterprise Value to EBITDA (EV/EBITDA)
22.60 0.00 16.48 7.41 26.32 0.00 9.68 11.31 7.80 6.24 8.81
Enterprise Value to EBIT (EV/EBIT)
0.00 0.00 36.59 12.44 0.00 0.00 14.63 15.37 9.87 8.12 13.50
Enterprise Value to NOPAT (EV/NOPAT)
0.00 0.00 0.00 13.07 0.00 0.00 12.24 19.65 11.48 9.79 17.46
Enterprise Value to Operating Cash Flow (EV/OCF)
10.47 0.00 18.90 9.33 11.54 11.99 13.52 17.93 10.73 7.53 9.84
Enterprise Value to Free Cash Flow (EV/FCFF)
33.56 0.00 0.00 21.67 19.45 4.40 0.00 37.42 16.79 14.24 17.31
Leverage & Solvency
- - - - - - - - - - -
Debt to Equity
0.99 1.31 1.31 1.08 1.29 1.83 1.36 1.02 0.81 0.74 0.68
Long-Term Debt to Equity
0.95 1.29 1.25 1.08 1.29 1.83 1.36 0.99 0.81 0.68 0.68
Financial Leverage
0.34 0.55 0.95 0.95 0.93 0.95 0.88 0.81 0.64 0.53 0.47
Leverage Ratio
2.17 2.56 2.93 2.85 2.92 3.54 3.67 3.10 2.75 2.52 2.40
Compound Leverage Factor
4.16 2.80 1.57 2.19 5.93 4.48 2.60 2.50 2.46 2.27 2.00
Debt to Total Capital
49.76% 56.72% 56.72% 51.93% 56.27% 64.70% 57.57% 50.54% 44.74% 42.52% 40.53%
Short-Term Debt to Total Capital
2.14% 0.78% 2.65% 0.00% 0.06% 0.00% 0.00% 1.39% 0.00% 3.51% 0.00%
Long-Term Debt to Total Capital
47.62% 55.95% 54.07% 51.93% 56.21% 64.70% 57.57% 49.15% 44.74% 39.01% 40.53%
Preferred Equity to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital
0.11% 0.18% 0.14% 0.11% 0.07% 0.06% 0.09% 0.18% 0.25% 0.23% 0.25%
Common Equity to Total Capital
50.13% 43.10% 43.14% 47.96% 43.66% 35.24% 42.34% 49.28% 55.02% 57.25% 59.23%
Debt to EBITDA
11.40 -2.26 3.87 2.59 9.63 -6.13 3.42 2.29 1.61 1.67 2.19
Net Debt to EBITDA
3.91 -1.53 3.04 2.09 7.52 -4.41 2.28 1.63 1.13 1.11 1.52
Long-Term Debt to EBITDA
10.91 -2.23 3.68 2.59 9.62 -6.13 3.42 2.23 1.61 1.53 2.19
Debt to NOPAT
-132.87 -2.61 -12.10 4.58 -32.93 -5.36 4.32 3.98 2.36 2.62 4.34
Net Debt to NOPAT
-45.62 -1.77 -9.51 3.69 -25.70 -3.85 2.88 2.84 1.66 1.74 3.00
Long-Term Debt to NOPAT
-127.16 -2.58 -11.53 4.58 -32.90 -5.36 4.32 3.87 2.36 2.41 4.34
Altman Z-Score
2.56 2.21 3.34 3.03 2.47 1.78 2.62 3.52 3.68 3.39 3.27
Noncontrolling Interest Sharing Ratio
0.20% 0.29% 0.37% 0.27% 0.20% 0.17% 0.20% 0.30% 0.41% 0.42% 0.41%
Liquidity Ratios
- - - - - - - - - - -
Current Ratio
3.76 2.90 2.22 2.32 2.30 2.14 2.31 2.05 2.06 2.05 2.04
Quick Ratio
2.88 1.97 1.52 1.51 1.40 1.27 1.56 1.30 1.27 1.28 1.28
Cash Flow Metrics
- - - - - - - - - - -
Free Cash Flow to Firm (FCFF)
907 -1,798 -36 1,359 1,450 5,122 -1,443 1,074 2,210 2,044 1,663
Operating Cash Flow to CapEx
144.15% -295.66% 203.13% 174.61% 182.46% 425.57% 352.58% 276.45% 292.06% 317.06% 273.71%
Free Cash Flow to Firm to Interest Expense
0.00 0.00 0.00 0.00 0.00 30.49 0.00 25.58 0.00 0.00 0.00
Operating Cash Flow to Interest Expense
0.00 0.00 0.00 0.00 0.00 11.20 0.00 53.38 0.00 0.00 0.00
Operating Cash Flow Less CapEx to Interest Expense
0.00 0.00 0.00 0.00 0.00 8.57 0.00 34.07 0.00 0.00 0.00
Efficiency Ratios
- - - - - - - - - - -
Asset Turnover
0.68 0.50 0.79 0.94 0.87 0.63 0.71 0.89 0.96 0.91 0.88
Accounts Receivable Turnover
3.67 3.44 4.60 4.67 4.57 3.78 4.54 4.90 4.85 4.60 4.41
Inventory Turnover
6.43 5.70 7.85 7.75 6.53 4.70 5.64 6.43 6.07 5.95 6.22
Fixed Asset Turnover
1.92 1.54 2.42 2.76 2.77 2.48 3.54 4.68 4.98 4.58 4.28
Accounts Payable Turnover
8.74 7.94 8.50 7.54 7.38 6.44 6.76 6.21 5.95 5.88 5.92
Days Sales Outstanding (DSO)
99.47 106.13 79.28 78.11 79.90 96.63 80.39 74.57 75.22 79.36 82.75
Days Inventory Outstanding (DIO)
56.74 64.02 46.47 47.12 55.93 77.64 64.73 56.78 60.15 61.34 58.71
Days Payable Outstanding (DPO)
41.78 45.97 42.96 48.40 49.43 56.66 53.96 58.82 61.31 62.02 61.70
Cash Conversion Cycle (CCC)
114.43 124.18 82.80 76.83 86.41 117.61 91.16 72.52 74.05 78.67 79.77
Capital & Investment Metrics
- - - - - - - - - - -
Invested Capital
20,764 17,823 16,954 17,848 16,084 9,257 12,811 13,783 14,805 15,734 15,457
Invested Capital Turnover
1.11 0.82 1.19 1.38 1.32 1.14 1.39 1.53 1.61 1.50 1.43
Increase / (Decrease) in Invested Capital
-1,022 -2,941 -869 894 -1,764 -6,827 3,554 972 1,022 929 -14
Enterprise Value (EV)
30,422 49,434 46,649 29,462 28,213 22,556 25,834 40,205 37,099 29,114 28,780
Market Capitalization
25,120 41,020 38,017 21,136 20,141 15,978 19,736 34,370 31,685 23,886 23,784
Book Value per Share
$18.07 $10.88 $9.54 $10.87 $9.13 $5.63 $7.50 $8.75 $10.49 $11.96 $12.43
Tangible Book Value per Share
$15.28 $8.09 $6.45 $7.64 $5.92 $2.45 $4.32 $5.64 $7.31 $8.73 $8.94
Total Capital
30,841 21,832 19,291 19,856 18,352 14,115 15,855 16,129 17,069 18,352 17,663
Total Debt
15,346 12,384 10,942 10,312 10,327 9,132 9,127 8,152 7,636 7,804 7,158
Total Long-Term Debt
14,687 12,214 10,430 10,312 10,316 9,132 9,127 7,928 7,636 7,160 7,158
Net Debt
5,269 8,375 8,605 8,304 8,059 6,569 6,083 5,806 5,372 5,186 4,952
Capital Expenditures (CapEx)
2,016 576 1,215 1,808 1,340 442 542 811 1,184 1,219 1,069
Debt-free, Cash-free Net Working Capital (DFCFNWC)
5,315 3,815 4,090 4,341 4,077 2,491 2,593 3,485 3,671 4,358 3,604
Debt-free Net Working Capital (DFNWC)
15,392 7,824 6,427 6,349 6,345 5,054 5,637 5,831 5,935 6,976 5,810
Net Working Capital (NWC)
14,733 7,654 5,915 6,349 6,334 5,054 5,637 5,607 5,935 6,332 5,810
Net Nonoperating Expense (NNE)
552 1,030 -437 596 815 1,237 643 451 570 457 357
Net Nonoperating Obligations (NNO)
5,269 8,375 8,605 8,304 8,059 4,274 6,083 5,806 5,372 5,186 4,952
Total Depreciation and Amortization (D&A)
1,835 1,503 1,556 1,606 1,625 1,058 904 940 998 1,079 1,136
Debt-free, Cash-free Net Working Capital to Revenue
22.49% 24.01% 19.84% 18.09% 18.19% 17.24% 16.95% 17.17% 15.95% 18.99% 16.25%
Debt-free Net Working Capital to Revenue
65.13% 49.25% 31.17% 26.46% 28.32% 34.99% 36.86% 28.73% 25.78% 30.40% 26.19%
Net Working Capital to Revenue
62.34% 48.18% 28.69% 26.46% 28.27% 34.99% 36.86% 27.62% 25.78% 27.60% 26.19%
Earnings Adjustments
- - - - - - - - - - -
Adjusted Basic Earnings per Share
($0.79) ($6.69) $0.00 $0.00 $0.00 ($3.34) $1.63 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic Shares Outstanding
853M 861M 874.91M 875M 875M 881M 1.80B 904M 899M 882M 853M
Adjusted Diluted Earnings per Share
($0.79) ($6.69) ($0.53) $1.89 ($1.29) ($3.34) $1.63 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Diluted Shares Outstanding
853M 861M 874.91M 877M 875M 881M 1.80B 908M 902M 883M 853M
Adjusted Basic & Diluted Earnings per Share
$0.00 $0.00 $0.00 $0.00 $0.00 ($3.34) $1.63 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
858.34M 866.93M 870M 872.54M 879.91M 1.78B 892M 1.81B 1.78B 868.09M 837.55M
Normalized Net Operating Profit after Tax (NOPAT)
1,624 451 1,415 2,496 1,441 954 1,268 2,323 3,232 3,064 2,255
Normalized NOPAT Margin
6.87% 2.84% 6.86% 10.40% 6.43% 6.61% 8.29% 11.44% 14.04% 13.35% 10.16%
Pre Tax Income Margin
-3.96% -48.00% 3.31% 7.56% -5.01% -22.29% 8.19% 10.40% 14.61% 14.10% 7.98%
Debt Service Ratios
- - - - - - - - - - -
EBIT to Interest Expense
0.00 0.00 0.00 0.00 0.00 -15.16 0.00 62.26 0.00 0.00 0.00
NOPAT to Interest Expense
0.00 0.00 0.00 0.00 0.00 -10.15 0.00 48.72 0.00 0.00 0.00
EBIT Less CapEx to Interest Expense
0.00 0.00 0.00 0.00 0.00 -17.79 0.00 42.95 0.00 0.00 0.00
NOPAT Less CapEx to Interest Expense
0.00 0.00 0.00 0.00 0.00 -12.78 0.00 29.41 0.00 0.00 0.00
Payout Ratios
- - - - - - - - - - -
Dividend Payout Ratio
-92.05% -10.75% -133.76% 38.02% -55.80% -9.45% 10.97% 27.27% 21.64% 23.85% 44.81%
Augmented Payout Ratio
-92.05% -10.75% -133.76% 62.16% -64.66% -12.85% 10.97% 42.95% 51.69% 63.79% 122.76%

Quarterly Metrics And Ratios for Halliburton

This table displays calculated financial ratios and metrics derived from Halliburton's official financial filings.

Metric Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026 Q2 2026
Period end date 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026 6/30/2026
DEI Shares Outstanding
- - - - - - - - - 837,548,345.00 835,397,735.00
DEI Adjusted Shares Outstanding
- - - - - - - - - 837,548,345.00 835,397,735.00
DEI Earnings Per Adjusted Shares Outstanding
- - - - - - - - - 0.55 0.64
Growth Metrics
- - - - - - - - - - -
Revenue Growth
2.81% 2.24% 0.60% -1.84% -2.25% -6.67% -5.54% -1.70% 0.84% -0.28% 3.70%
EBITDA Growth
-12.50% -2.48% 3.97% -13.98% 6.18% -41.42% -23.07% -45.64% -12.07% 41.41% 5.67%
EBIT Growth
-17.43% -5.48% 2.33% -18.91% 5.79% -55.40% -30.53% -62.52% -17.51% 66.07% 6.26%
NOPAT Growth
9.64% -1.06% 0.56% -16.03% -14.61% -62.56% -28.59% -95.28% -4.11% 93.65% 10.37%
Net Income Growth
-0.60% -7.02% 14.63% -19.89% -7.11% -66.67% -32.68% -96.55% -4.07% 128.57% 12.08%
EPS Growth
0.00% -5.56% 17.65% -17.72% 0.00% -64.71% -31.25% -96.92% 61.97% 129.17% 16.36%
Operating Cash Flow Growth
21.24% 299.18% 2.76% -3.78% 3.26% -22.59% -17.11% -41.97% -19.99% -27.59% -8.04%
Free Cash Flow Firm Growth
12.08% 46.11% 37.80% 63.80% -17.25% -155.31% 133.19% 145.84% 1,169.16% 266.11% 708.32%
Invested Capital Growth
7.41% 6.44% 6.82% 5.87% 6.27% 4.65% 3.26% -0.34% -0.09% -1.02% 0.70%
Revenue Q/Q Growth
-1.12% 1.13% 0.50% -2.33% -1.53% -3.44% 1.72% 1.63% 1.02% -4.51% 5.78%
EBITDA Q/Q Growth
-14.30% -6.55% 12.35% -15.12% 5.79% -41.93% 47.53% -40.02% 72.30% -7.25% 10.25%
EBIT Q/Q Growth
-17.92% -9.01% 15.13% -19.07% 7.08% -55.30% 79.34% -56.33% 137.79% -10.82% 14.75%
NOPAT Q/Q Growth
3.11% -9.63% 4.72% -13.95% 4.85% -60.38% 99.75% -94.31% 2,028.36% -19.98% 13.85%
Net Income Q/Q Growth
-8.70% -8.70% 17.08% -18.65% 5.86% -66.94% 136.45% -95.83% 2,845.00% -21.22% 15.95%
EPS Q/Q Growth
0.00% 0.00% 17.65% -18.75% 0.00% 0.00% 129.17% -96.36% -4,150.00% 167.90% 16.36%
Operating Cash Flow Q/Q Growth
61.33% -65.46% 121.97% -22.20% 73.13% -74.11% 137.67% -45.54% 138.73% -76.57% 201.83%
Free Cash Flow Firm Q/Q Growth
66.08% 61.44% -14.16% 2.31% -9.87% -108.35% 114.84% 34.90% 716.03% 1.66% -27.77%
Invested Capital Q/Q Growth
-0.88% 2.40% 0.76% 1.72% -0.50% 2.62% -0.58% -1.83% -1.92% 3.40% 1.15%
Profitability Metrics
- - - - - - - - - - -
Gross Margin
19.74% 18.64% 19.25% 18.78% 18.29% 16.23% 14.86% 15.29% 16.44% 14.49% 14.07%
EBITDA Margin
18.91% 19.68% 22.00% 19.12% 20.53% 12.35% 17.91% 10.57% 18.03% 17.51% 18.25%
Operating Margin
18.44% 17.01% 17.69% 15.29% 16.61% 7.96% 13.19% 6.36% 13.19% 12.57% 13.62%
EBIT Margin
14.45% 15.14% 17.35% 14.38% 15.63% 7.24% 12.76% 5.48% 12.90% 12.05% 13.07%
Profit (Net Income) Margin
11.52% 10.49% 12.22% 10.18% 10.94% 3.75% 8.71% 0.36% 10.41% 8.59% 9.42%
Tax Burden Percent
79.16% 77.38% 77.50% 79.02% 77.43% 66.34% 78.56% 9.13% 92.76% 81.55% 81.02%
Interest Burden Percent
100.72% 89.53% 90.91% 89.62% 90.42% 78.06% 86.91% 71.34% 86.99% 87.40% 88.89%
Effective Tax Rate
20.12% 22.62% 22.50% 20.98% 22.57% 33.66% 21.44% 90.87% 7.24% 18.45% 18.98%
Return on Invested Capital (ROIC)
23.71% 20.36% 21.12% 18.13% 19.33% 7.54% 14.59% 0.81% 17.55% 14.15% 15.32%
ROIC Less NNEP Spread (ROIC-NNEP)
20.42% 17.73% 19.59% 16.20% 17.29% 6.10% 12.93% 0.59% 15.46% 12.50% 13.58%
Return on Net Nonoperating Assets (RNNOA)
13.11% 11.54% 11.82% 9.29% 9.14% 3.49% 6.91% 0.31% 7.25% 6.41% 6.68%
Return on Equity (ROE)
36.82% 31.90% 32.94% 27.42% 28.46% 11.03% 21.50% 1.13% 24.80% 20.56% 22.00%
Cash Return on Invested Capital (CROIC)
15.46% 15.31% 14.85% 14.43% 13.39% 11.31% 11.18% 10.92% 10.75% 12.94% 11.57%
Operating Return on Assets (OROA)
13.87% 14.52% 16.34% 13.33% 14.27% 6.55% 11.23% 4.81% 11.32% 10.62% 11.42%
Return on Assets (ROA)
11.06% 10.06% 11.51% 9.44% 9.99% 3.39% 7.67% 0.31% 9.13% 7.57% 8.23%
Return on Common Equity (ROCE)
36.67% 31.76% 32.80% 27.29% 28.34% 10.98% 21.41% 1.12% 24.70% 20.47% 21.91%
Return on Equity Simple (ROE_SIMPLE)
0.00% 27.15% 27.07% 24.89% 0.00% 20.35% 17.87% 0.00% 0.00% 0.00% 0.00%
Net Operating Profit after Tax (NOPAT)
845 764 800 688 722 286 571 33 692 554 630
NOPAT Margin
14.73% 13.16% 13.71% 12.08% 12.86% 5.28% 10.37% 0.58% 12.23% 10.25% 11.03%
Net Nonoperating Expense Percent (NNEP)
3.29% 2.62% 1.53% 1.93% 2.04% 1.44% 1.66% 0.23% 2.09% 1.65% 1.74%
Return On Investment Capital (ROIC_SIMPLE)
4.95% - - - 3.93% 1.59% 3.16% 0.18% 3.92% 3.08% 3.46%
Cost of Revenue to Revenue
80.26% 81.36% 80.75% 81.22% 81.71% 83.77% 85.14% 84.71% 83.56% 85.51% 85.93%
SG&A Expenses to Revenue
1.05% 1.05% 1.06% 0.97% 1.09% 1.14% 1.09% 1.04% 1.04% 1.15% 1.31%
R&D to Revenue
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Expenses to Revenue
1.31% 1.64% 1.56% 3.49% 1.68% 8.27% 1.67% 8.93% 3.25% 1.93% 0.46%
Earnings before Interest and Taxes (EBIT)
829 879 1,012 819 877 392 703 307 730 651 747
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
1,085 1,142 1,283 1,089 1,152 669 987 592 1,020 946 1,043
Valuation Ratios
- - - - - - - - - - -
Price to Book Value (P/BV)
3.37 3.66 2.99 2.49 2.27 2.12 1.67 2.06 2.27 3.03 2.58
Price to Tangible Book Value (P/TBV)
4.84 5.20 4.19 3.44 3.12 2.95 2.32 2.89 3.16 4.19 3.55
Price to Revenue (P/Rev)
1.38 1.52 1.29 1.11 1.04 0.98 0.79 0.95 1.07 1.47 1.27
Price to Earnings (P/E)
12.01 13.61 11.11 10.07 9.55 10.49 9.41 16.02 18.54 21.21 17.70
Dividend Yield
1.81% 1.65% 1.95% 2.31% 2.50% 2.68% 3.34% 2.76% 2.41% 1.74% 2.00%
Earnings Yield
8.33% 7.35% 9.00% 9.93% 10.47% 9.53% 10.63% 6.24% 5.39% 4.72% 5.65%
Enterprise Value to Invested Capital (EV/IC)
2.51 2.66 2.28 1.97 1.85 1.72 1.44 1.68 1.86 2.37 2.07
Enterprise Value to Revenue (EV/Rev)
1.61 1.77 1.53 1.35 1.27 1.23 1.04 1.20 1.30 1.71 1.50
Enterprise Value to EBITDA (EV/EBITDA)
7.80 8.69 7.42 6.78 6.24 6.63 5.92 7.80 8.81 10.68 9.31
Enterprise Value to EBIT (EV/EBIT)
9.87 11.08 9.50 8.81 8.12 8.97 8.27 11.64 13.50 15.83 13.76
Enterprise Value to NOPAT (EV/NOPAT)
11.48 12.74 10.98 10.07 9.79 11.11 10.14 15.89 17.46 19.77 16.97
Enterprise Value to Operating Cash Flow (EV/OCF)
10.73 10.74 9.20 8.16 7.53 7.40 6.46 8.25 9.84 13.42 12.19
Enterprise Value to Free Cash Flow (EV/FCFF)
16.79 17.93 15.86 14.04 14.24 15.57 13.06 15.39 17.31 18.21 17.99
Leverage & Solvency
- - - - - - - - - - -
Debt to Equity
0.81 0.79 0.76 0.74 0.74 0.72 0.72 0.74 0.68 0.66 0.65
Long-Term Debt to Equity
0.81 0.79 0.76 0.74 0.68 0.69 0.68 0.70 0.68 0.65 0.64
Financial Leverage
0.64 0.65 0.60 0.57 0.53 0.57 0.53 0.53 0.47 0.51 0.49
Leverage Ratio
2.75 2.66 2.62 2.55 2.52 2.48 2.45 2.45 2.40 2.37 2.37
Compound Leverage Factor
2.77 2.38 2.38 2.28 2.27 1.94 2.13 1.75 2.09 2.07 2.11
Debt to Total Capital
44.74% 44.10% 43.19% 42.46% 42.52% 42.01% 41.70% 42.39% 40.53% 39.81% 39.32%
Short-Term Debt to Total Capital
0.00% 0.00% 0.00% 0.00% 3.51% 2.12% 2.11% 2.15% 0.00% 0.50% 0.49%
Long-Term Debt to Total Capital
44.74% 44.10% 43.19% 42.46% 39.01% 39.89% 39.59% 40.24% 40.53% 39.31% 38.82%
Preferred Equity to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital
0.25% 0.27% 0.26% 0.31% 0.23% 0.23% 0.23% 0.24% 0.25% 0.25% 0.23%
Common Equity to Total Capital
55.02% 55.64% 56.55% 57.23% 57.25% 57.75% 58.07% 57.37% 59.23% 59.94% 60.45%
Debt to EBITDA
1.61 1.62 1.60 1.66 1.67 1.80 1.94 2.22 2.19 2.02 1.99
Net Debt to EBITDA
1.13 1.22 1.15 1.19 1.11 1.37 1.41 1.62 1.52 1.45 1.42
Long-Term Debt to EBITDA
1.61 1.62 1.60 1.66 1.53 1.71 1.84 2.11 2.19 1.99 1.96
Debt to NOPAT
2.36 2.37 2.37 2.47 2.62 3.01 3.32 4.51 4.34 3.74 3.63
Net Debt to NOPAT
1.66 1.78 1.70 1.76 1.74 2.29 2.42 3.30 3.00 2.69 2.59
Long-Term Debt to NOPAT
2.36 2.37 2.37 2.47 2.41 2.86 3.15 4.29 4.34 3.69 3.58
Altman Z-Score
3.29 3.50 3.29 3.12 3.04 2.91 2.76 2.85 3.09 3.48 3.24
Noncontrolling Interest Sharing Ratio
0.41% 0.42% 0.43% 0.49% 0.42% 0.44% 0.43% 0.48% 0.41% 0.41% 0.39%
Liquidity Ratios
- - - - - - - - - - -
Current Ratio
2.06 2.12 2.13 2.21 2.05 1.98 2.00 1.95 2.04 2.08 2.02
Quick Ratio
1.27 1.30 1.34 1.38 1.28 1.20 1.20 1.21 1.28 1.30 1.25
Cash Flow Metrics
- - - - - - - - - - -
Free Cash Flow to Firm (FCFF)
-177 -169 -193 -189 -207 -432 64 87 706 718 518
Operating Cash Flow to CapEx
414.71% 173.31% 375.35% 282.21% 413.64% 149.01% 285.35% 230.19% 401.72% 182.00% 528.21%
Free Cash Flow to Firm to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Operating Cash Flow to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Operating Cash Flow Less CapEx to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Efficiency Ratios
- - - - - - - - - - -
Asset Turnover
0.96 0.96 0.94 0.93 0.91 0.91 0.88 0.88 0.88 0.88 0.87
Accounts Receivable Turnover
4.85 4.50 4.51 4.41 4.60 4.38 4.32 4.22 4.41 4.26 4.35
Inventory Turnover
6.07 5.86 5.74 5.72 5.95 5.86 5.81 5.90 6.22 6.20 6.20
Fixed Asset Turnover
4.98 4.94 4.85 4.77 4.58 4.46 4.31 4.38 4.28 4.29 4.29
Accounts Payable Turnover
5.95 5.97 5.78 5.98 5.88 5.90 5.65 5.99 5.92 5.89 5.68
Days Sales Outstanding (DSO)
75.22 81.20 80.88 82.76 79.36 83.39 84.52 86.56 82.75 85.62 83.98
Days Inventory Outstanding (DIO)
60.15 62.26 63.58 63.85 61.34 62.31 62.88 61.85 58.71 58.92 58.85
Days Payable Outstanding (DPO)
61.31 61.10 63.19 61.08 62.02 61.89 64.59 60.89 61.70 61.99 64.23
Cash Conversion Cycle (CCC)
74.05 82.36 81.27 85.53 78.67 83.81 82.81 87.53 79.77 82.55 78.60
Capital & Investment Metrics
- - - - - - - - - - -
Invested Capital
14,805 15,428 15,546 15,813 15,734 16,146 16,053 15,759 15,457 15,982 16,165
Invested Capital Turnover
1.61 1.55 1.54 1.50 1.50 1.43 1.41 1.40 1.43 1.38 1.39
Increase / (Decrease) in Invested Capital
1,022 933 993 877 929 718 507 -54 -14 -164 112
Enterprise Value (EV)
37,099 41,075 35,451 31,163 29,114 27,802 23,069 26,530 28,780 37,858 33,517
Market Capitalization
31,685 35,283 29,905 25,646 23,886 22,023 17,521 20,974 23,784 32,656 28,362
Book Value per Share
$10.49 $10.84 $11.30 $11.66 $11.96 $11.94 $12.22 $11.97 $12.43 $12.87 $13.18
Tangible Book Value per Share
$7.31 $7.63 $8.07 $8.45 $8.73 $8.61 $8.77 $8.52 $8.94 $9.30 $9.56
Total Capital
17,069 17,319 17,684 17,991 18,352 17,950 18,091 17,785 17,663 17,985 18,213
Total Debt
7,636 7,637 7,638 7,639 7,804 7,541 7,544 7,539 7,158 7,160 7,161
Total Long-Term Debt
7,636 7,637 7,638 7,639 7,160 7,160 7,163 7,157 7,158 7,070 7,071
Net Debt
5,372 5,746 5,500 5,461 5,186 5,737 5,506 5,513 4,952 5,157 5,113
Capital Expenditures (CapEx)
340 281 288 298 352 253 314 212 290 150 156
Debt-free, Cash-free Net Working Capital (DFCFNWC)
3,671 4,153 4,164 4,405 4,358 4,283 4,170 4,040 3,604 4,085 4,037
Debt-free Net Working Capital (DFNWC)
5,935 6,044 6,302 6,583 6,976 6,087 6,208 6,066 5,810 6,088 6,085
Net Working Capital (NWC)
5,935 6,044 6,302 6,583 6,332 5,706 5,827 5,684 5,810 5,998 5,995
Net Nonoperating Expense (NNE)
184 155 87 108 108 83 91 13 103 90 92
Net Nonoperating Obligations (NNO)
5,372 5,746 5,500 5,461 5,186 5,737 5,506 5,513 4,952 5,157 5,113
Total Depreciation and Amortization (D&A)
256 263 271 270 275 277 284 285 290 295 296
Debt-free, Cash-free Net Working Capital to Revenue
15.95% 17.94% 17.96% 19.09% 18.99% 18.99% 18.76% 18.25% 16.25% 18.43% 18.04%
Debt-free Net Working Capital to Revenue
25.78% 26.11% 27.19% 28.53% 30.40% 26.99% 27.92% 27.40% 26.19% 27.46% 27.20%
Net Working Capital to Revenue
25.78% 26.11% 27.19% 28.53% 27.60% 25.30% 26.21% 25.68% 26.19% 27.06% 26.80%
Earnings Adjustments
- - - - - - - - - - -
Adjusted Basic Earnings per Share
$0.00 $680,000.00 $800,000.00 $650,000.00 $0.00 $0.24 $0.55 $0.02 ($0.81) $0.55 $0.64
Adjusted Weighted Average Basic Shares Outstanding
899M 889M 884M 881M 882M 866M 857M 849M 853M 837M 836M
Adjusted Diluted Earnings per Share
$0.00 $680,000.00 $800,000.00 $650,000.00 $0.00 $0.24 $0.55 $0.02 ($0.81) $0.55 $0.64
Adjusted Weighted Average Diluted Shares Outstanding
902M 891M 886M 881M 883M 866M 857M 850M 853M 839M 838M
Adjusted Basic & Diluted Earnings per Share
$0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
1.78B 1.77B 1.77B 878.50M 868.09M 859.72M 852.60M 841.63M 837.55M 835.40M 833.13M
Normalized Net Operating Profit after Tax (NOPAT)
845 764 800 780 722 522 571 524 769 554 553
Normalized NOPAT Margin
14.73% 13.16% 13.71% 13.69% 12.86% 9.64% 10.37% 9.35% 13.59% 10.25% 9.68%
Pre Tax Income Margin
14.55% 13.56% 15.77% 12.88% 14.14% 5.65% 11.09% 3.91% 11.23% 10.53% 11.62%
Debt Service Ratios
- - - - - - - - - - -
EBIT to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
NOPAT to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
EBIT Less CapEx to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
NOPAT Less CapEx to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Payout Ratios
- - - - - - - - - - -
Dividend Payout Ratio
21.64% 22.25% 21.76% 23.22% 23.85% 28.25% 31.43% 44.34% 44.81% 36.96% 35.51%
Augmented Payout Ratio
51.69% 58.56% 56.93% 60.28% 63.79% 75.88% 85.35% 125.28% 122.76% 92.14% 85.66%

Financials Breakdown Chart

Key Financial Trends

Halliburton’s latest results show a meaningful recovery from the weakness seen in 2025, although revenue and gross margins remain below their 2024 peak. In Q2 2026, revenue increased to $5.71 billion, up 5.8% from Q1 2026 and approximately 3.7% from the restated Q2 2025 figure. Gross profit was $804 million, producing a 14.1% gross margin compared with 14.9% a year earlier. Operating income rose to $778 million from $679 million in Q1, while net income attributable to common shareholders reached $534 million, or $0.64 per diluted share, versus $461 million and $0.55 per share in Q1.

Profitability has improved considerably from the restructuring-affected quarters of 2025. Halliburton reported restructuring charges of $356 million in Q1 2025 and $392 million in Q3 2025. The latest quarter included a negative $95 million restructuring charge, which appears to represent a benefit rather than an expense in the standardized data. Investors should therefore distinguish between underlying operating performance and the effect of these unusual restructuring entries. Even with that data caveat, Q2 2026 operating income was substantially above the $356 million reported in Q3 2025.

Cash generation also improved sequentially. Operating cash flow climbed to $824 million in Q2 2026 from $273 million in Q1, and capital expenditures were $235 million, implying approximate free cash flow of $589 million. Halliburton continued returning capital through $208 million of share repurchases and $143 million of dividends. However, operating cash flow was still below the $896 million generated in Q2 2025 and well below the unusually strong $1.17 billion recorded in Q4 2025.

The balance sheet remains stable but leveraged. Cash and equivalents increased to $2.05 billion from $2.00 billion in Q1, while total debt was approximately $7.16 billion, essentially unchanged sequentially and below the roughly $7.93 billion reported at the end of 2022. Total equity increased to $11.05 billion from $7.98 billion at the end of 2022. Halliburton’s current ratio was approximately 2.0, supported by $11.88 billion of current assets against $5.89 billion of current liabilities.

  • Revenue momentum returned: Q2 2026 revenue rose to $5.71 billion, increasing both sequentially and year over year.
  • Net income and EPS improved: Net income attributable to common shareholders increased to $534 million, while diluted EPS rose to $0.64 from $0.55 in Q1 2026.
  • Operating profitability recovered: Operating income reached $778 million, well above the restructuring-affected results reported during much of 2025.
  • Strong quarterly free cash flow: Operating cash flow of $824 million exceeded capital spending by approximately $589 million.
  • Shareholder returns remain substantial: The company repurchased $208 million of stock and paid $143 million in dividends during Q2 2026.
  • Long-term balance-sheet progress: Total debt declined from approximately $7.93 billion at the end of 2022 to about $7.16 billion in Q2 2026, while equity increased.
  • Working-capital movements are volatile: Changes in operating assets and liabilities contributed $65 million of cash in Q2 2026, reversing the $252 million use of cash in Q1.
  • Restructuring accounting complicates comparisons: Large charges in 2025 and a reported negative charge in Q2 2026 make reported operating expenses and margins less representative of recurring performance.
  • Gross-margin pressure persists: Q2 2026 gross margin was approximately 14.1%, below the 20%-plus levels reported in several 2023 and 2024 quarters.
  • Interest expense remains a drag: Net interest and other expense reduced Q2 2026 pretax income by $114 million, highlighting the ongoing cost of Halliburton’s debt load.
09/09/26 03:23 AM ETAI Generated. May Contain Errors.

Halliburton Financials - Frequently Asked Questions

According to the most recent income statement we have on file, Halliburton's financial year ends in December. Their financial year 2025 ended on December 31, 2025.

Halliburton's net income appears to be on an upward trend, with a most recent value of $1.29 billion in 2025, falling from -$667 million in 2015. The previous period was $2.52 billion in 2024. View Halliburton's forecast to see where analysts expect Halliburton to go next.

Halliburton's total operating income in 2025 was $2.26 billion, based on the following breakdown:
  • Total Gross Profit: $3.48 billion
  • Total Operating Expenses: $1.22 billion

Over the last 10 years, Halliburton's total revenue changed from $23.63 billion in 2015 to $22.18 billion in 2025, a change of -6.1%.

Halliburton's total liabilities were at $14.51 billion at the end of 2025, a 3.6% decrease from 2024, and a 32.4% decrease since 2015.

In the past 10 years, Halliburton's cash and equivalents has ranged from $2.01 billion in 2018 to $10.08 billion in 2015, and is currently $2.21 billion as of their latest financial filing in 2025.

Over the last 10 years, Halliburton's book value per share changed from 18.07 in 2015 to 12.43 in 2025, a change of -31.2%.



Financial statements for NYSE:HAL last updated on 7/24/2026 by MarketBeat.com Staff. New filings and market data are monitored continuously.
From Our Partners